ProfileGDS4718 / 232624_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 55% 56% 58% 62% 56% 56% 56% 64% 62% 56% 62% 53% 58% 56% 55% 56% 59% 55% 55% 56% 62% 58% 61% 57% 55% 59% 51% 53% 53% 54% 55% 51% 62% 53% 55% 57% 56% 55% 61% 56% 56% 57% 53% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.8045455
GSM549102patient 115, normal, homogenized [OPG study]5.9066556
GSM549104patient 119, normal, homogenized [OPG study]6.0263158
GSM549108patient 138, normal, homogenized [OPG study]6.2737462
GSM549119patient 077, normal, homogenized [OPG study]5.8551556
GSM549133patient 032, cancer, homogenized [OPG study]5.8330556
GSM549139patient 042, cancer, homogenized [OPG study]5.8792656
GSM549099patient 107, normal, homogenized [OPG study]6.3839464
GSM549109patient 139, normal, homogenized [OPG study]6.2463562
GSM549110patient 046, normal, homogenized [OPG study]5.8725156
GSM549114patient 063, normal, homogenized [OPG study]6.2252962
GSM549122patient 082, normal, homogenized [OPG study]5.6710853
GSM549134patient 033, cancer, homogenized [OPG study]5.9692658
GSM549136patient 036, cancer, homogenized [OPG study]5.8543556
GSM549140patient 044, cancer, homogenized [OPG study]5.7984655
GSM549111patient 047, normal, homogenized [OPG study]5.8380656
GSM549113patient 057, normal, homogenized [OPG study]6.0572459
GSM549132patient 031, cancer, homogenized [OPG study]5.8281255
GSM549137patient 038, cancer, homogenized [OPG study]5.8116755
GSM549142patient 047, cancer, homogenized [OPG study]5.9836456
GSM549100patient 110, normal, homogenized [OPG study]6.250762
GSM549107patient 135, normal, homogenized [OPG study]5.9508558
GSM549115patient 068, normal, homogenized [OPG study]6.1544861
GSM549116patient 072, normal, homogenized [OPG study]5.9048657
GSM549120patient 078, normal, homogenized [OPG study]5.7822755
GSM549131patient 030, cancer, homogenized [OPG study]6.0160259
GSM549118patient 074, normal, homogenized [OPG study]5.5929851
GSM549129patient 027, cancer, homogenized [OPG study]5.7336953
GSM549123patient 088, normal, homogenized [OPG study]5.674353
GSM549124patient 006, cancer, homogenized [OPG study]5.7577854
GSM549126patient 015, cancer, homogenized [OPG study]5.8188755
GSM549128patient 025, cancer, homogenized [OPG study]5.5420851
GSM549103patient 117, normal, homogenized [OPG study]6.2719362
GSM549117patient 073, normal, homogenized [OPG study]5.6662553
GSM549138patient 041, cancer, homogenized [OPG study]5.8024955
GSM549141patient 045, cancer, homogenized [OPG study]5.9460157
GSM549130patient 028, cancer, homogenized [OPG study]5.8814356
GSM549101patient 111, normal, homogenized [OPG study]5.8654355
GSM549105patient 128, normal, homogenized [OPG study]6.1704161
GSM549106patient 134, normal, homogenized [OPG study]5.8062156
GSM549112patient 048, normal, homogenized [OPG study]5.8836856
GSM549125patient 011, cancer, homogenized [OPG study]5.9186657
GSM549127patient 024, cancer, homogenized [OPG study]5.6805753
GSM549135patient 035, cancer, homogenized [OPG study]5.7533955